GALWAY, IRELAND--March 10, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--German drugmaker Merck KGaA is offloading its Allergopharma allergy business to Dermapharm, a leading manufacturer of off-patent branded medicines for selected markets in Germany. Within this article: Details sale of Merck allergy business Allergopharma, refocus of Merck on biosimilars
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!
